Cargando…

The Endogenous Th17 Response in NO(2)-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer

Severe, glucocorticoid-resistant asthma comprises 5-7% of patients with asthma. IL-17 is a biomarker of severe asthma, and the adoptive transfer of Th17 cells in mice is sufficient to induce glucocorticoid-resistant allergic airway disease. Nitrogen dioxide (NO(2)) is an environmental toxin that cor...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Rebecca A., Ather, Jennifer L., Daggett, Rebecca, Hoyt, Laura, Alcorn, John F., Suratt, Benjamin T., Weiss, Daniel J., Lundblad, Lennart K. A., Poynter, Matthew E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778003/
https://www.ncbi.nlm.nih.gov/pubmed/24069338
http://dx.doi.org/10.1371/journal.pone.0074730
_version_ 1782285054129471488
author Martin, Rebecca A.
Ather, Jennifer L.
Daggett, Rebecca
Hoyt, Laura
Alcorn, John F.
Suratt, Benjamin T.
Weiss, Daniel J.
Lundblad, Lennart K. A.
Poynter, Matthew E.
author_facet Martin, Rebecca A.
Ather, Jennifer L.
Daggett, Rebecca
Hoyt, Laura
Alcorn, John F.
Suratt, Benjamin T.
Weiss, Daniel J.
Lundblad, Lennart K. A.
Poynter, Matthew E.
author_sort Martin, Rebecca A.
collection PubMed
description Severe, glucocorticoid-resistant asthma comprises 5-7% of patients with asthma. IL-17 is a biomarker of severe asthma, and the adoptive transfer of Th17 cells in mice is sufficient to induce glucocorticoid-resistant allergic airway disease. Nitrogen dioxide (NO(2)) is an environmental toxin that correlates with asthma severity, exacerbation, and risk of adverse outcomes. Mice that are allergically sensitized to the antigen ovalbumin by exposure to NO(2) exhibit a mixed Th2/Th17 adaptive immune response and eosinophil and neutrophil recruitment to the airway following antigen challenge, a phenotype reminiscent of severe clinical asthma. Because IL-1 receptor (IL-1R) signaling is critical in the generation of the Th17 response in vivo, we hypothesized that the IL-1R/Th17 axis contributes to pulmonary inflammation and airway hyperresponsiveness (AHR) in NO(2)-promoted allergic airway disease and manifests in glucocorticoid-resistant cytokine production. IL-17A neutralization at the time of antigen challenge or genetic deficiency in IL-1R resulted in decreased neutrophil recruitment to the airway following antigen challenge but did not protect against the development of AHR. Instead, IL-1R-/- mice developed exacerbated AHR compared to WT mice. Lung cells from NO(2)-allergically inflamed mice that were treated in vitro with dexamethasone (Dex) during antigen restimulation exhibited reduced Th17 cytokine production, whereas Th17 cytokine production by lung cells from recipient mice of in vitro Th17-polarized OTII T-cells was resistant to Dex. These results demonstrate that the IL-1R/Th17 axis does not contribute to AHR development in NO(2)-promoted allergic airway disease, that Th17 adoptive transfer does not necessarily reflect an endogenously-generated Th17 response, and that functions of Th17 responses are contingent on the experimental conditions in which they are generated.
format Online
Article
Text
id pubmed-3778003
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37780032013-09-25 The Endogenous Th17 Response in NO(2)-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer Martin, Rebecca A. Ather, Jennifer L. Daggett, Rebecca Hoyt, Laura Alcorn, John F. Suratt, Benjamin T. Weiss, Daniel J. Lundblad, Lennart K. A. Poynter, Matthew E. PLoS One Research Article Severe, glucocorticoid-resistant asthma comprises 5-7% of patients with asthma. IL-17 is a biomarker of severe asthma, and the adoptive transfer of Th17 cells in mice is sufficient to induce glucocorticoid-resistant allergic airway disease. Nitrogen dioxide (NO(2)) is an environmental toxin that correlates with asthma severity, exacerbation, and risk of adverse outcomes. Mice that are allergically sensitized to the antigen ovalbumin by exposure to NO(2) exhibit a mixed Th2/Th17 adaptive immune response and eosinophil and neutrophil recruitment to the airway following antigen challenge, a phenotype reminiscent of severe clinical asthma. Because IL-1 receptor (IL-1R) signaling is critical in the generation of the Th17 response in vivo, we hypothesized that the IL-1R/Th17 axis contributes to pulmonary inflammation and airway hyperresponsiveness (AHR) in NO(2)-promoted allergic airway disease and manifests in glucocorticoid-resistant cytokine production. IL-17A neutralization at the time of antigen challenge or genetic deficiency in IL-1R resulted in decreased neutrophil recruitment to the airway following antigen challenge but did not protect against the development of AHR. Instead, IL-1R-/- mice developed exacerbated AHR compared to WT mice. Lung cells from NO(2)-allergically inflamed mice that were treated in vitro with dexamethasone (Dex) during antigen restimulation exhibited reduced Th17 cytokine production, whereas Th17 cytokine production by lung cells from recipient mice of in vitro Th17-polarized OTII T-cells was resistant to Dex. These results demonstrate that the IL-1R/Th17 axis does not contribute to AHR development in NO(2)-promoted allergic airway disease, that Th17 adoptive transfer does not necessarily reflect an endogenously-generated Th17 response, and that functions of Th17 responses are contingent on the experimental conditions in which they are generated. Public Library of Science 2013-09-19 /pmc/articles/PMC3778003/ /pubmed/24069338 http://dx.doi.org/10.1371/journal.pone.0074730 Text en © 2013 Martin et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Martin, Rebecca A.
Ather, Jennifer L.
Daggett, Rebecca
Hoyt, Laura
Alcorn, John F.
Suratt, Benjamin T.
Weiss, Daniel J.
Lundblad, Lennart K. A.
Poynter, Matthew E.
The Endogenous Th17 Response in NO(2)-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer
title The Endogenous Th17 Response in NO(2)-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer
title_full The Endogenous Th17 Response in NO(2)-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer
title_fullStr The Endogenous Th17 Response in NO(2)-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer
title_full_unstemmed The Endogenous Th17 Response in NO(2)-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer
title_short The Endogenous Th17 Response in NO(2)-Promoted Allergic Airway Disease Is Dispensable for Airway Hyperresponsiveness and Distinct from Th17 Adoptive Transfer
title_sort endogenous th17 response in no(2)-promoted allergic airway disease is dispensable for airway hyperresponsiveness and distinct from th17 adoptive transfer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778003/
https://www.ncbi.nlm.nih.gov/pubmed/24069338
http://dx.doi.org/10.1371/journal.pone.0074730
work_keys_str_mv AT martinrebeccaa theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT atherjenniferl theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT daggettrebecca theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT hoytlaura theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT alcornjohnf theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT surattbenjamint theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT weissdanielj theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT lundbladlennartka theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT poyntermatthewe theendogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT martinrebeccaa endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT atherjenniferl endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT daggettrebecca endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT hoytlaura endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT alcornjohnf endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT surattbenjamint endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT weissdanielj endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT lundbladlennartka endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer
AT poyntermatthewe endogenousth17responseinno2promotedallergicairwaydiseaseisdispensableforairwayhyperresponsivenessanddistinctfromth17adoptivetransfer